Product
Diphtheria, Tetanus, Pertussis, Poliomyelitis and Haemophilus Influenzae Type B Conjugate Vaccine
1 clinical trial
3 indications
Indication
DiphtheriaIndication
TetanusIndication
PertussisClinical trial
A Randomized,Blind, Positive-controlled Phase I Clinical Trial to Preliminary Evaluate the Safety of DTcP Vaccine in Healthy Children Aged Between 2 Months and 6 YearsStatus: Completed, Estimated PCD: 2021-10-27